Introduction: Malignant pleural mesothelioma (MPM) is a rapidly progressive tumor that is increasing in frequency worldwide. Treatment options are limited, and response to chemotherapy is poor.

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

The EC approves BMY's combination of Opdivo and Yervoy for the first-line treatment of adult patients with unresectable or ...

Q4 2024 Earnings Call Transcript February 28, 2025 Butterfly Network, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.09. Operator: Good morning, and welcome to the ...

Read the full guideline update, “Treatment of Pleural Mesothelioma: ASCO Guideline Update ... She discusses changes for patients with EGFR driver alterations in both the first- and second-line setting ...

In stage 1A2, the tumor is between 1 cm and 2 cm across and hasn’t affected the bronchi or penetrated the visceral pleura (T1b), which covers the surface of each lung. It also hasn’t reached ...

We propose pioneering path planning methods along intercostal spaces and innovative solutions for adaptive probe posture adjustment using real-time pleural line feedback, specifically addressing the ...

Chest CT (coronal and sagittal) before intrapleural therapy, showing the presence of moderate left loculated pleural effusion (red asterisk and dotted line) (A). Chest CT (coronal and sagittal) after ...

Typically, smoking cessation is the first line of treatment. Medications ... Pleurisy results from inflammation of the pleura, the thin membrane surrounding the lungs and the chest cavity. Symptoms ...